OptimizeRx Corp Files Q2 2024 10-Q Report
Ticker: OPRX · Form: 10-Q · Filed: Aug 15, 2024 · CIK: 1448431
| Field | Detail |
|---|---|
| Company | Optimizerx CORP (OPRX) |
| Form Type | 10-Q |
| Filed Date | Aug 15, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
OptimizeRx Corp dropped its Q2 10-Q. Check financials.
AI Summary
OptimizeRx Corp filed its 10-Q for the quarterly period ended June 30, 2024. The company, incorporated in Nevada, is headquartered in Waltham, MA. This filing provides an update on its financial performance and business operations for the specified quarter.
Why It Matters
This filing provides investors with crucial financial and operational details for OptimizeRx Corp, enabling informed investment decisions regarding the company's performance in the second quarter of 2024.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new risks indicated in the provided header information.
Key Players & Entities
- OptimizeRx Corp (company) — Registrant
- June 30, 2024 (date) — Quarterly period end date
- 20240815 (date) — Filing date
- Nevada (location) — State of incorporation
- Waltham, MA (location) — Principal executive offices address
FAQ
What is the filing date of this 10-Q report?
The filing date of this 10-Q report for OptimizeRx Corp is August 15, 2024.
What period does this 10-Q report cover?
This 10-Q report covers the quarterly period ended June 30, 2024.
Where is OptimizeRx Corp's principal executive office located?
OptimizeRx Corp's principal executive office is located at 260 Charles Street, Suite 302, Waltham, MA 02453.
What is the state of incorporation for OptimizeRx Corp?
OptimizeRx Corp is incorporated in Nevada.
What is the SEC file number for OptimizeRx Corp?
The SEC file number for OptimizeRx Corp is 001-38543.
Filing Stats: 4,671 words · 19 min read · ~16 pages · Grade level 18.8 · Accepted 2024-08-15 16:30:19
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 OPRX Nasdaq Capital Market Indicate b
Filing Documents
- ea0211425-10q_optimizerx.htm (10-Q) — 532KB
- ea021142501ex31-1_optimizerx.htm (EX-31.1) — 9KB
- ea021142501ex31-2_optimizerx.htm (EX-31.2) — 9KB
- ea021142501ex32-1_optimizerx.htm (EX-32.1) — 5KB
- 0001213900-24-069700.txt ( ) — 3459KB
- oprx-20240630.xsd (EX-101.SCH) — 35KB
- oprx-20240630_cal.xml (EX-101.CAL) — 37KB
- oprx-20240630_def.xml (EX-101.DEF) — 160KB
- oprx-20240630_lab.xml (EX-101.LAB) — 295KB
- oprx-20240630_pre.xml (EX-101.PRE) — 159KB
- ea0211425-10q_optimizerx_htm.xml (XML) — 294KB
– FINANCIAL INFORMATION
PART I – FINANCIAL INFORMATION Item 1:
Financial Statements (unaudited)
Financial Statements (unaudited) 1 Item 2:
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 17 Item 3:
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 24 Item 4:
Controls and Procedures
Controls and Procedures 24
– OTHER
PART II – OTHER INFORMATION Item 1:
Legal Proceedings
Legal Proceedings 25 Item 1A:
Risk Factors
Risk Factors 25 Item 2: Unregistered Sales of Equity Securities and Use of Proceeds 25 Item 3: Defaults Upon Senior Securities 25 Item 4: Mine Safety Disclosure 25 Item 5: Other Information 25 Item 6: Exhibits 25 i
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements Our condensed consolidated financial statements included in this Form 10-Q are as follows: 2 Condensed Consolidated Balance Sheets as of June 30, 2024 (unaudited) and December 31, 2023 (unaudited); 3 Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2024 and 2023 (unaudited); 4 Condensed Consolidated Statements of Changes in Stockholders' Equity for the three and six months June 30, 2024 and 2023 (unaudited); 6 Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2024 and 2023 (unaudited); 7 Notes to Condensed Consolidated Financial Statements (unaudited). 1 OPTIMIZERX CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share data, unaudited) June 30, 2024 December 31, 2023 ASSETS Current assets Cash and cash equivalents $ 14,959 $ 13,852 Accounts receivable, net of allowance for credit losses of $ 371 and $ 480 at June 30, 2024 and December 31, 2023, respectively 24,521 36,253 Taxes receivable 1,842 1,036 Prepaid expenses and other 4,647 3,190 Total current assets 45,969 54,331 Property and equipment, net 171 149 Other assets Goodwill 78,357 78,357 Other intangibles, net 14,470 15,198 Tradename and customer relationships, net 33,003 34,198 Operating lease right of use assets, net 472 573 Security deposits and other assets 434 568 Total other assets 126,736 128,894 TOTAL ASSETS $ 172,876 $ 183,374 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities Current portion of long-term debt $ 3,300 $ 2,000 Accounts payable – trade 2,980 2,227 Accrued expenses 5,310 7,706 Revenue share payable 2,094 5,506 Taxes payable — 49 Current portion of lease liabilities 219 222 Deferred revenue 1,053 172 Total current liabilities 14,956 17,882 Non-current liabilities Long-term debt, net 32,296 34,231 Lease liabilities, net